Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 16,300	$ 3,914	$ 29,875	$ 8,048
General and administrative	3,813	1,145	7,606	2,097
Total operating expenses	20,113	5,059	37,481	10,145
Loss from operations	(20,113)	(5,059)	(37,481)	(10,145)
Other income (expense), net	187	0	280	(5)
Net loss	$ (19,926)	$ (5,059)	$ (37,201)	$ (10,150)
Net loss per share, basic (in dollars per share)	$ (0.86)	$ (4.84)	$ (1.60)	$ (10.98)
Net loss per share, diluted (in dollars per share)	$ (0.86)	$ (4.84)	$ (1.60)	$ (10.98)
Weighted average common shares outstanding, basic (in shares)	23,258,759	1,046,228	23,237,600	924,131
Weighted average common shares outstanding, diluted (in shares)	23,258,759	1,046,228	23,237,600	924,131